Form 4 for IMVT Immunovant, Inc.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001764013-22-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-12 | 2022-01-10 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +21.7K | 88.9K | +32% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +71.5K | 131.8K | +119% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | A | A | 21,726 | $0.00 | 88,926 | D | — | — | (F1) Represents the number of shares underlying restricted stock units awards ("RSUs"). (F2) The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. |
| 2 | Derivative | Stock Option (right to buy) | 2022-01-10 | A | A | 71,492 | $0.00 | 131,792 | D | $7.94 · — to 2032-01-10 | 71,492 Common Stock | (F3) Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. |